Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
A legfontosabb adatok
- Ki végzi
- Joseph Valentino, MD
- Hol
- Bowling Green, Lexington és Owensboro (Egyesült Államok)Mind a 3 helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Fázis
- 2. fázis
- Résztvevők
- 126 fő vett részt
- Kezdés
- 2021. jan. 12.
- Befejezés
- 2026. jan. 2.
- A vizsgálat típusa
- Beavatkozással járó, 12 csoport
- A vizsgált kezelések
- Varenicline
- Bupropion
- Long-acting nicotine replacement therapy
- Low-intensity counseling
- High-intensity counseling
- No nicotine replacement therapy
- Nicotine Replacement Products
- A regiszteradat frissítve
- 2026. november 5.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- newly diagnosed or recurrent tobacco related malignancy
- smoked at least 1 cigarette within 4 weeks of study enrollment
- 10-pack year history of cigarette smoking
- smoked at least 1 cigarette within 1 month of cancer diagnosis
- life expectancy greater than 1 year
Ki nem vehet részt
- concurrent enrollment in tobacco cessation therapy
- allergy to buproprion, varenicline and transdermal medicine
- history of suicide attempt
- hospitalized for psychiatric illness within past 2 years
- history of active or uncontrolled eating disorder
- uncontrolled epilepsy or seizure disorder
- within 3 months of myocardial infarction
- unstable angina
- uncontrolled hypertension
- serious arrhythmia
- history of taking varenicline or buproprion within one month of enrollment
- pregnant or lactating
Helyszínek itt: Egyesült Államok
- Med Center HealthBowling Green, Egyesült Államok
- University of Kentucky/Markey Cancer CenterLexington, Egyesült Államok
- Owensboro Health Mitchell Memorial Cancer CenterOwensboro, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking cessation therapy will be the principal determinant by providers in developing a three component regimen of pharmaceutical therapy, counseling, and nicotine replacement therapy. This study will identify this cohort's preferences for smoking cessation strategies. We will then examine the impact of utilizing patient preferences upon cessation efficacy by directly comparing cessation success in this study with our recently completed study of the same population using the same tobacco treatments which were randomly assigned.
A vizsgálat 12 csoportja
- Group 1: Nicotine, Intense Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive long acting nicotine replacement therapy (e.g. nicotine patch), counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Long-acting nicotine replacement therapy, High-intensity counseling és Nicotine Replacement Products
- Group 2: Buproprion, Intense Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive Buproprion, counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Bupropion, High-intensity counseling és Nicotine Replacement Products
- Group 3: Varenicline, Intense Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive varenicline, counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Varenicline, High-intensity counseling és Nicotine Replacement Products
- Group 4: Nicotine, Intense CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive long acting nicotine replacement therapy (e.g. nicotine patch) and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Long-acting nicotine replacement therapy, High-intensity counseling és No nicotine replacement therapy
- Group 5: Buproprion, Intense CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive Buproprion and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Bupropion, High-intensity counseling és No nicotine replacement therapy
- Group 6: Varenicline, Intense CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive varenicline and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Varenicline, High-intensity counseling és No nicotine replacement therapy
- Group 7: Nicotine, Minimal Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive long acting nicotine replacement therapy (e.g. nicotine patch), counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Long-acting nicotine replacement therapy, Low-intensity counseling és Nicotine Replacement Products
- Group 8: Buproprion, Minimal Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive Buproprion, counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Bupropion, Low-intensity counseling és Nicotine Replacement Products
- Group 9: Varenicline, Minimal Counselling and NRTA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive varenicline, counseling, and nicotine replacement therapy (PRN NRT). Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Varenicline, Low-intensity counseling és Nicotine Replacement Products
- Group 10: Nicotine, Minimal CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive long acting nicotine replacement therapy (e.g. nicotine patch) and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Long-acting nicotine replacement therapy, Low-intensity counseling és No nicotine replacement therapy
- Group 11: Buproprion, Minimal CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive Buproprion and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Bupropion, Low-intensity counseling és No nicotine replacement therapy
- Group 12: Varenicline, Minimal CounsellingA vizsgált kezelés
Patients diagnosed with tobacco-related treatment will receive varenicline and counseling. Dose and frequency will be based on patient preference, smoking history and other medical factors.
Kezelés: Varenicline, Low-intensity counseling és No nicotine replacement therapy
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2026. november 5.